Completed PHASE3 INTERVENTIONAL 4-arm NCT00970879

Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine (PACOME)

Prevention of Pregnancy-associated Malaria in HIV-infected Women : Randomised Controlled Trial Testing Cotrimoxazole Prophylaxis Versus Intermittent Preventive Treatment With Mefloquine

Sponsor: Institut de Recherche pour le Developpement

Conditions HIV Infections Malaria in Pregnancy

Interventions cotrimoxazole mefloquine

Updated 5 times since 2017 Last updated: Jan 21, 2013 Started: Dec 31, 2009 Primary completion: Jul 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on HIV Infections and Malaria in Pregnancy, this trial is completed. The trial is conducted by Institut de Recherche pour le Developpement and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut de Recherche pour le Developpement
Ministry of Health, Benin
National University Hospital, Cotonou
Saint Antoine University Hospital
Sidaction
Université d'Abomey-Calavi

Data source: Institut de Recherche pour le Developpement

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cotonou, Benin
• Porto-Novo, Benin